|
Antitumor B-carboline derivatives |
|
Principal Investigator: A. JOSSANG and G. UZAN
|
TECHNICAL DESCRIPTION
This invention describes, in immunodeficient animal model, the use of a novel combination of compounds displaying antitumoral activities against xenografted human tumor by oral administration. The said combination includes a Peganum harmala derivatives with 30 % of therapeutic dose of a DNA synthesis or replication inhibitors that are currently used as anticancer therapeutic agents with known side effects.
Pour lire la suite, merci de vous identifier ou de vous inscrire dans la zone de droite... |
